Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

COVID-19 GPH|Home|PHGKB Last data update: Jan 21, 2021 . (Total: 19209 Documents since 2020)

Last Posted: Jan-21-2021 10:26:48
spot light Spotlight

COVID-19 and People with Developmental and Behavioral Disorders
CDC, January 20, 2021

Most people with developmental or behavioral disorders are not naturally at higher risk for becoming infected with or having severe illness from novel coronavirus (COVID-19). However, people with developmental or behavioral disorders who have serious underlying medical conditions may be at risk of serious illness.

COVID-19 and Rural Communities
CDC, January 20, 2021

About 46 million Americans live in rural areas, which face distinctive challenges during the COVID-19 pandemic. Long-standing systemic health and social inequities have put some rural residents at increased risk of getting COVID-19 or having severe illness.

SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn
M Connors et al, Ann Int Med, January 19, 2021

Although the initial data on efficacy and safety are extraordinarily encouraging, many questions remain regarding who should receive these vaccines and the immediate, intermediate, and long-term impact of the vaccination program on the pandemic.

Covid-19: What new variants are emerging and how are they being investigated?
A Mahase, BMJ, January 18, 2021

The three main vaccines all target the spike protein of the virus, where these variants have mutations. Researchers are still fairly confident, however, that the vaccines will work against them—although they are not sure whether protection could be reduced—because the spike protein is so large that many mutations would be needed to completely escape. Studies are now underway to test whether the vaccines are effective against these new variants.

news Latest News and Publications
US needs national COVID 'smart testing' strategy, APHL says
McLemon LM. CIDRAP, Jan 19, 2020.

New Added Today

Pivotal Year for Preprints
Burke L. Inside Higher Ed, Jan 20, 2021.

New Added Today

What new COVID variants mean for schools is not yet clear Children are no more susceptible to these lineages than adults are — and closing schools on the basis of incomplete information could have repercussions.
D Lewis, Nature News, January 21, 2021

New Added Today

Epidemic waves of COVID-19 in Scotland: a genomic perspective on the impact of the introduction and relaxation of lockdown on SARS-CoV-2
SJ Lycett et al, MEDRXIV, January 20, 2021

New Added Today

Factors associated with COVID-19 related hospitalisation, critical care admission and mortality using linked primary and secondary care data
L Cummings et al, MEDRXIV, January 20, 2021

New Added Today

Impact of SARS-CoV-2 B.1.1.7 Spike variant on neutralisation potency of sera from individuals vaccinated with Pfizer vaccine BNT162b2
D Collier et al, MEDRXIV, January 20, 2021

New Added Today

Modelling pooling strategies for SARS-CoV-2 testing in a university setting
G Hemami et al, MEDRXIV, January 20, 2021

New Added Today

Overcrowding and Exposure to Secondhand Smoke Increase Risk for COVID-19 Infection Among Latinx Families in Greater San Francisco Bay Area
AD Mendez et al, MEDRXIV, January 20, 2021

New Added Today

Modeling the population effects of epitope specific escape mutations in SARS-CoV-2 to guide vaccination strategies
JS Koopman et al, MEDRXIV, January 20, 2021

New Added Today

Head-to-head comparison of direct-input RT-PCR and RT-LAMP against RTqPCR on extracted RNA for rapid SARS-CoV-2 diagnostics
MJ Kellner et al, MEDRXIV, January 20, 2021

New Added Today

All Latest

Sign up Email Alert

Content Statistics

  • Total (19209)
  • Genomics Precision Health (15620)
  • Non-Genomics Precision Health (3585)

About COVID-19 GPH

COVID-19 GPH is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that captures emerging discoveries and applications of genomics, molecular and other precision medicine and precision public health tools in the investigation and control of COVID-19. Contents include PubMed records via an automated pubmed search algorithm, preprint records from NIH iCite, the relevant information from many media sources picked by experts, and linkages to contents from our curated PHGKB databases.

Genomics Precision Health (GPH): The use of pathogen and human genomics and advanced molecular detection methods in discovery, clinical and public health investigations involving COVID-19.
Non Genomics Precision Health (non-GPH): The use of big data, data science and machine learning methods (not involving genomics) in discovery, clinical and public health investigations involving COVID-19

Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.